Purchase Order 1333ND21PNB640152

Award Date 5/3/21
Potential Completion Date 5/2/26
Potential Value $2.2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20899, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health Office of the Director awarded a $1,199,996.98 cost-no-fee delivery order to the National Academy of Sciences, a non-profit organization, for a "Forum on Regenerative Medicine" with a completion date of January 16, 2024. The contract does not have a set-aside designation. The National Academy of Sciences has extensive experience providing various research, analysis, advisory, and technical support services to...
This is a $1,405,000.00 firm fixed price purchase order contract awarded by the National Human Genome Research Institute, a component of the Department of Health and Human Services, to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for services related to beta cell differentiation and cell assays, which aligns with the original solicitation that sought the development of assays to evaluate the differentiation of stem cells into insulin-producing beta cells. No...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a sole-source, firm fixed-price purchase order contract to Nexight Group LLC, a regulatory consulting firm, to provide Standards Development for Regenerative Medicine Therapies. The contract has a potential value of $936,040.00 and a completion date of July 30, 2020. The FDA determined that Nexight Group's existing deliverables and expertise were required to ensure consistency and integrity of the overall...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price purchase order contract worth $265,048.50 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of assorted cell culture medium, substrate, and supplements manufactured by Life Technologies. This contract supports the Stem Cell Translation Laboratory within the National...
This $238,000.00 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to the New York Stem Cell Foundation, Inc., a non-profit organization that conducts stem cell research. The contract is for the derivation of induced pluripotent stem cells, which aligns with the foundation's work in generating stem cell lines, differentiating them into various cell types, and...
This is a firm fixed-price delivery order awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, to Prometheus Computing, LLC, a woman-owned small business. The $85,108.90 contract is for developing medical device standards information modeling and a device specialization builder. This task order is under a larger $45 million NIST information technology and database application IDIQ contract vehicle that Prometheus holds. The award supports NIST's...
This is a $15,375 firm-fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation, Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells,...
This is a $18,772.80 firm fixed-price purchase order awarded to Stemcell Technologies Inc. by the National Institutes of Health (NIH) Clinical Center on November 13, 2024. Stemcell Technologies Inc. is a subsidiary of the Canadian biotechnology company Stemcell Technologies. This contract is not set aside for small businesses. The award provides specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives...
Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $150,000.00 firm fixed-price purchase order contract to the New York Stem Cell Foundation Inc., a non-profit organization that conducts stem cell research. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines, differentiating stem cells into insulin-producing beta cells, and expanding and validating neural...

The Department of Commerce National Institute of Standards and Technology (NIST) awarded a $2,214,773.00 Firm Fixed Price Purchase Order to the Standards Coordinating Body For Gene Cell & Regenerative Medicines, a Non-Profit Organization, for the development of STANDARDS DEVELOPMENT FOR REGENERATIVE MEDICINE THERAPIES. The contract has a completion date of May 2, 2026 and does not utilize a set-aside designation. This work supports NIST's role in developing standards and measurement tools to advance regenerative medicine therapies.

Generated 5/3/24, 10:10 AM